主要文件

查看所有文档

861650

(+)-生物素 4-硝基苯酯

Name: (+)-生物素 4-硝基苯酯
Brand: ALDRICH

98%

别名:

4-硝基苯基 (+)-生物素酯, d-生物素对硝基苯酯, BNP

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₁₆H₁₉N₃O₅S

化学文摘社编号:

33755-53-2

分子量:

365.40

UNSPSC Code:

12352108

NACRES:

NA.22

PubChem Substance ID:

24888552

MDL number:

MFCD15141972

Beilstein/REAXYS Number:

5795805

Assay:

98%

Form:

powder

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

Quality Level

200

assay

98%

form

powder

optical activity

[α]25/D +51°, c = 2 in DMF: AcOH (99:1)

mp

163-165 °C (lit.)

solubility

methanol: 25 mg/mL, clear, colorless to greenish-yellow

functional group

ester, nitro, thioether

SMILES string

[O-][N+](=O)c1ccc(OC(=O)CCCC[C@@H]2SCC3NC(=O)NC23)cc1

InChI

1S/C16H19N3O5S/c20-14(24-11-7-5-10(6-8-11)19(22)23)4-2-1-3-13-15-12(9-25-13)17-16(21)18-15/h5-8,12-13,15H,1-4,9H2,(H2,17,18,21)/t12-,13-,15-/m0/s1

InChI key

YUDNXDTXQPYKCA-YDHLFZDLSA-N

说明

Application

(+)-生物素-4-硝基苯酯可用于在细胞蛋白摄取研究中制备生物素标记ARC（腺苷-寡聚精氨酸偶联物）衍生物。也可用于制备生物素化喹唑啉衍生物抑制VEGFR-2酪氨酸（血管内皮生长因子受体-2）激酶活性。(+)-生物素-4-硝基苯酯在Na[¹⁷O]H存在下，水解形成[¹⁷O₂]生物素用于¹⁷O核磁共振波谱法分析蛋白-配体大复合物。

使用Synple自动合成平台(SYNPLE-SC002)实现自动化生物素标记

Packaging

无底玻璃瓶。内含物装在插入的融合锥内。

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Identification of the ability of highly charged nanomolar inhibitors of protein kinases to cross plasma membranes and carry a protein into cells.

Uri A, et al.

Bioorganic & Medicinal Chemistry Letters, 12(16), 2117-2120 (2002)

Predictors of cardiac function in acute heart failure patients with mid-range ejection fraction: AURORA study.

Kyosuke Yanagawa et al.

ESC heart failure, 6(4), 817-823 (2019-06-22)

The factors correlated with prognosis in heart failure with mid-range ejection fraction (HFmrEF) is unclear, especially for acute heart failure (AHF) with HFmrEF. Thus, we investigated the factors correlated with the improvement in the ejection fraction (EF) over 1 year in

Validation of the Boston University staging system in AL amyloidosis.

Ross Tomlinson et al.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 26(3), 125-127 (2019-05-31)

Objectives: We aimed to externally validate Lilleness' et al. Boston University (BU) prognostic score that replaced NT-proBNP with brain natriuretic peptide (BNP), which will allow centres without access to NT-proBNP to accurately stage and prognosticate AL amyloidosis. Patients/methods: Forty-four were identified

查看所有相关文献

全球贸易项目编号

货号	GTIN
861650-100MG	04061833552483
861650-25MG	04061833282243